Cromolyn Sodium (Prasco Laboratories)
Welcome to the PulseAid listing for the Cromolyn Sodium drug offered from Prasco Laboratories. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prasco Laboratories |
NON-PROPRIETARY NAME: | Cromolyn Sodium |
SUBSTANCE NAME: | CROMOLYN SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2011-12-12 |
END MARKETING DATE: | 2018-01-31 |
Cromolyn Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Cromolyn Sodium from Prasco Laboratories |
LABELER NAME: | Prasco Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2011-12-12 |
END MARKETING DATE: | 2018-01-31 |
PRODUCT ID: | 66993-470_7840578e-fcd2-4af3-9b2c-cc42ed7033bb |
PRODUCT NDC: | 66993-470 |
APPLICATION NUMBER: | NDA020479 |
Other CROMOLYN SODIUM Pharmaceutical Manufacturers / Labelers: